Celin Tompkins

1.0k total citations
3 papers, 65 citations indexed

About

Celin Tompkins is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Celin Tompkins has authored 3 papers receiving a total of 65 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Celin Tompkins's work include Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and HER2/EGFR in Cancer Research (1 paper). Celin Tompkins is often cited by papers focused on Lung Cancer Treatments and Mutations (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and HER2/EGFR in Cancer Research (1 paper). Celin Tompkins collaborates with scholars based in United States and Switzerland. Celin Tompkins's co-authors include Jennifer L. Harris, Shailaja Kasibhatla, Auzon Steffy, Shifeng Pan, Mindy H. Hsieh, Wenqi Gao, H. Martin Seidel, Chun Li, Nicholas Ng and Fangxian Sun and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and ACS Medicinal Chemistry Letters.

In The Last Decade

Celin Tompkins

3 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celin Tompkins United States 3 43 22 17 14 7 3 65
Auzon Steffy United States 3 43 1.0× 22 1.0× 13 0.8× 16 1.1× 7 1.0× 5 70
SeongShick Ryu South Korea 4 47 1.1× 22 1.0× 6 0.4× 10 0.7× 6 0.9× 10 57
Sudeep Prajapati Italy 4 36 0.8× 11 0.5× 12 0.7× 17 1.2× 3 0.4× 7 60
Lenora A. Pluchino United States 4 35 0.8× 22 1.0× 6 0.4× 5 0.4× 2 0.3× 4 70
Laura Fankhauser United Kingdom 2 31 0.7× 18 0.8× 20 1.2× 2 0.1× 5 0.7× 2 51
Ann Maria United States 3 35 0.8× 18 0.8× 7 0.4× 4 0.3× 3 0.4× 5 43
Sioban Fraser United Kingdom 3 36 0.8× 14 0.6× 7 0.4× 6 0.4× 2 0.3× 3 54
Peter Kasan Slovakia 3 15 0.3× 28 1.3× 19 1.1× 4 0.3× 2 0.3× 5 41
Kara M. Soroko United States 3 58 1.3× 37 1.7× 11 0.6× 6 0.4× 1 0.1× 6 82
John A. Moral United States 3 22 0.5× 29 1.3× 14 0.8× 26 1.9× 4 85

Countries citing papers authored by Celin Tompkins

Since Specialization
Citations

This map shows the geographic impact of Celin Tompkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celin Tompkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celin Tompkins more than expected).

Fields of papers citing papers by Celin Tompkins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celin Tompkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celin Tompkins. The network helps show where Celin Tompkins may publish in the future.

Co-authorship network of co-authors of Celin Tompkins

This figure shows the co-authorship network connecting the top 25 collaborators of Celin Tompkins. A scholar is included among the top collaborators of Celin Tompkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celin Tompkins. Celin Tompkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Dai, Cheng, Jun Liu, Dong Han, et al.. (2016). Discovery of Pyridinyl Acetamide Derivatives as Potent, Selective, and Orally Bioavailable Porcupine Inhibitors. ACS Medicinal Chemistry Letters. 7(7). 676–680. 44 indexed citations
2.
Kasibhatla, Shailaja, Jie Li, Celin Tompkins, et al.. (2014). Abstract 1733: EGF816, a novel covalent inhibitor of mutant-selective epidermal growth factor receptor, overcomes T790M-mediated resistance in NSCLC. Cancer Research. 74(19_Supplement). 1733–1733. 8 indexed citations
3.
Li, Nanxin, Pierre‐Yves Michellys, Sung Joon Kim, et al.. (2011). Abstract B232: Activity of a potent and selective phase I ALK inhibitor LDK378 in naive and crizotinib-resistant preclinical tumor models.. Molecular Cancer Therapeutics. 10(11_Supplement). B232–B232. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Auzon Steffy Breakdown of academic impact, for papers by SeongShick Ryu Breakdown of academic impact, for papers by Sudeep Prajapati Breakdown of academic impact, for papers by Lenora A. Pluchino Breakdown of academic impact, for papers by Laura Fankhauser Breakdown of academic impact, for papers by Ann Maria Breakdown of academic impact, for papers by Sioban Fraser Breakdown of academic impact, for papers by Peter Kasan Breakdown of academic impact, for papers by Kara M. Soroko Breakdown of academic impact, for papers by John A. Moral
Rankless by CCL
2026